Corporate Profile

Shiratori Pharmaceutical is a flexible company
bursting with creative strengths.

Utilizing natural ingredients as our starting point, we have been involved for many years in the development of active pharmaceutical ingredients and intermediates, functional organic compounds and beauty and health food products.
Our entire workforce constantly strives to be innovative, flexible and creative.
As a company that has grown on the basis of a research and development model, Shiratori Pharmaceutical believes that its mission is to promote human health and science beauty in concert with our clients.

  • Quality Control

  • Head Office

  • Reserch & Development

  • Manufacturing

  • Laboratory

  • Chiba Plant

  • Tokyo Office

Corporate Profile

Company name
Shiratori Pharmaceutical Co., Ltd.
Head office
WBG Marive East 28F,
2-6-1 Nakase, Mihama-ku,Chiba-shi, Chiba MAP MAP
TEL : +81(43)307-8977(main)
FAX : +81(43)299-8970
Tokyo office
12 Higashi-Matsusitacho, kanda, chiyoda-ku, Tokyo MAP MAP
TEL : +81(3)3526-2588(main)
FAX : +81(3)3258-6072
Originally founded
1916
Established
1948
Capital
95 million yen (As of April 1, 2022)
Directors
Chairperson of the Board
Yutaka Shiratori
Representative Director and President
Satoshi Shiratori
Vice President
Kiyomi Hatano
Executive Director
Akihiko Hosokai
Executive Director
Hiroshi Yoshino
Executive Director
Shigeya Sumita
Director
Yukio Ookawa
Director
Shinnosuke Tazawa
Director
Tomoyuki Wakino
Director
Hiroyuki Sugano
No. of employees
202 (As of September 1, 2024)
Annual turnover
5.6 billion yen (As of August 31, 2023)
Trading banks
Chiba Bank, Chiba Kogyo Bank, Sumitomo-Mitsui Banking Corporation, Mizuho Bank, The Bank of Tokyo-Mitsubishi UFJ, Keiyo Bank, Shokochukin Bank
Business Contents
Manufacture of APIs
Manufacture of fine chemicals
Manufacture of raw materials for food additive ・Manufacture of health foods
Contract research / manufacture of APIs and intermediates
Plants
Chiba Plant
54 Shinminato, Mihama-ku, Chiba-shi, Chiba
MAP MAP
TEL: +81(43)242-7631
FAX: +81(43)246-7473
Technology Development
6-11-24 Tsudanuma, Narashino-shi, Chiba
MAP MAP
TEL: +81(47)452-3192
FAX: +81(47)452-3193
Quality Control Center
Shinminato Plant
14-5 Shinminato, Mihama-ku, Chiba-shi, Chiba
MAP MAP
Affiliates
Shiratori Yakuhin Co., Ltd.
Seiko Yakuhin Kogyo Co., Ltd.
Shiratori Wellpharma Co., Ltd.

Corporate History

1916
Shiratori Seiyakusho Co., Ltd. founded
1948
Company name changed to Shiratori Pharmaceutical Co., Ltd.
1969
Chiba plant opened to produce natural and synthetic caffeine
1977
Research and Development center opened in Tsudanuma.
1996
Chiba plant granted cGMP certification by US FDA
2003
Chiba plant obtained ISO14001 certification
2010
Chiba plant received FDA audit without FDA-483
2012
Chiba plant obtained FSSC22000.
2013
Akanehama laboratory opened to produce highly potent APIs.
2016
Quality Control center opened in Shinminato.
2017
Tokyo sales office opened in Kanda.
2019
Head office was relocated to Makuhari New City.
2023
Akanehama laboratory rebuiled to produce highly potent APIs.
Environmental Policy

Shiratori Pharmaceutical Co., Ltd. Chiba Plant defines the entries described below as the Environmental Policy for all operations involved in the manufacture of active pharmaceutical ingredients, food additives and functional organic compounds in order to act with a consciousness of environmental conservation of the abundant Earth and resource recycling-oriented society.

  • We strive for the prevention of environmental pollution by promoting further energy/resource saving and the reduction of industrial waste along with pressing ahead with appropriate managements of chemical substances and our effluent treatment facility.
  • We strive for environmental conservation by complying with environment-related laws, regulations and other requirements.
  • We promote the establishment of an environmental management system and continuous improvements of environmental load reduction for operations in our plant.
  • We establish environmental goals for environmental objectives described below and strive for the achievement of them along with conducting a regular review of them.
    　1) Prevention of global warning (Promotion of energy-saving activities)
    　2) Appropriate management and reduction of industrial wastes 　3) Appropriate management of our effluent treatment facility 　4) Appropriate management of chemical substances and resource saving 　5) Promotion of environmental education
  • This Policy will be reviewed as necessary, disseminated to all employees and released to persons outside the company.
May 14, 2019
Satoshi Shiratori
President,
Shiratori Pharmaceutical Co., Ltd.